Answers are grounded in this paper and cite their sources.
This perspective suggests a circadian framework for evaluating neutrophil-to-lymphocyte ratio in immunotherapy, indicating time-of-day impacts on toxicity.
Immune indices such as the neutrophil-to-lymphocyte ratio (NLR) are widely used to monitor patients on immune checkpoint inhibitors, yet their interpretation rarely consider time-of-day biology. This perspective proposes a circadian framework in which sampling time and treatment timing shape baseline values, short-term fluctuations, and prognostic thresholds. Drawing on clinical observations across lungs, renal, and other tumors, I outline how morning versus afternoon therapy and corticosteroid administration may differentially modulate NLR trajectories and toxicity and introduce practical steps for time-adjusted reporting: record clock time, analyze intra-patient trends, and compare like-for-like time windows. Integrating chronobiology into routine hematologic
No takes yet. Share an insight, caveat, or question.
Ivan Bivolarski (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: